Genome-wide kinase-MAM interactome screening reveals the role of CK2A1 in MAM Ca 2+ dynamics linked to DEE66.
Truong Thi My NhungNguyen Phuoc LongTran Diem NghiYeongjun SuhNguyen Hoang AnhCheol Woon JungHong Minh TrietMin-Kyo JungYoungsik WooJin Yeong YooSujin NohSoo Jeong KimSu Been LeeSeongoh ParkGary ThomasThomas SimmenJiyoung MunHyun-Woo RheeSung Won KwonSang Ki ParkPublished in: Proceedings of the National Academy of Sciences of the United States of America (2023)
The endoplasmic reticulum (ER) and mitochondria form a unique subcellular compartment called mitochondria-associated ER membranes (MAMs). Disruption of MAMs impairs Ca 2+ homeostasis, triggering pleiotropic effects in the neuronal system. Genome-wide kinase-MAM interactome screening identifies casein kinase 2 alpha 1 (CK2A1) as a regulator of composition and Ca 2+ transport of MAMs. CK2A1-mediated phosphorylation of PACS2 at Ser207/208/213 facilitates MAM localization of the CK2A1-PACS2-PKD2 complex, regulating PKD2-dependent mitochondrial Ca 2+ influx. We further reveal that mutations of PACS2 (E209K and E211K) associated with developmental and epileptic encephalopathy-66 (DEE66) impair MAM integrity through the disturbance of PACS2 phosphorylation at Ser207/208/213. This, in turn, causes the reduction of mitochondrial Ca 2+ uptake and the dramatic increase of the cytosolic Ca 2+ level, thereby, inducing neurotransmitter release at the axon boutons of glutamatergic neurons. In conclusion, our findings suggest a molecular mechanism that MAM alterations induced by pathological PACS2 mutations modulate Ca 2+ -dependent neurotransmitter release.